Basilea Pharmaceutica AG
BPMUF
$71.00
-$0.60-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.13% | 18.33% | |||
| Total Other Revenue | 0.13% | 88.26% | |||
| Total Revenue | 0.13% | 27.38% | |||
| Cost of Revenue | 0.13% | 36.38% | |||
| Gross Profit | 0.13% | 13.79% | |||
| SG&A Expenses | 0.13% | 8.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.13% | 30.30% | |||
| Operating Income | 0.13% | 17.85% | |||
| Income Before Tax | 0.13% | 41.42% | |||
| Income Tax Expenses | 0.13% | -39.11% | |||
| Earnings from Continuing Operations | 0.13% | 59.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.13% | 59.47% | |||
| EBIT | 0.13% | 17.85% | |||
| EBITDA | 0.13% | 22.48% | |||
| EPS Basic | 0.14% | 59.48% | |||
| Normalized Basic EPS | 0.13% | 41.42% | |||
| EPS Diluted | 0.13% | 53.89% | |||
| Normalized Diluted EPS | 0.13% | 44.84% | |||
| Average Basic Shares Outstanding | 0.00% | -0.01% | |||
| Average Diluted Shares Outstanding | 0.00% | -2.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||